Galectin-3, Metabolic Risk, and Incident Heart Failure: The ARIC Study.

Justin Basile Echouffo-Tcheugui Sui Zhang Roberta Florido James S Pankow Erin Donelly MichosRonald B GoldbergVijay Nambi Gary Gerstenblith Wendy S Post Roger Scott Blumenthal Christie M Ballantyne Josef Coresh Elizabeth Selvin Chiadi E Ndumele

Published in: Journal of the American Heart Association (2024)

MetS and diabetes are associated with elevated Gal-3. The HF risk significantly increased with the combination of greater metabolic risk and higher Gal-3.

Keyphrases

heart failure
cardiovascular disease
type diabetes
left ventricular
adipose tissue
acute heart failure
weight loss
breast cancer risk